Business Context and Reporting Period
Company: Golden Sun Health Technology Group Limited (Golden Sun Technology Group Ltd.)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2025 (Report Date: August 29, 2025)
Context: The filing addresses the Company's compliance status with The Nasdaq Stock Market LLC listing requirements.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance regarding stockholders' equity rather than detailed financial performance metrics.
Material Changes
Listing Compliance: On August 27, 2025, the Company received formal notice from Nasdaq confirming compliance with Listing Rule 5550(b)(1) (the "Minimum Stockholders' Equity Rule") and all other applicable criteria for continued listing on The Nasdaq Capital Market.
Outlook, Risks, and Management Commentary
- Ongoing Monitoring: Nasdaq will continue to monitor the Company to ensure ongoing compliance with the Minimum Stockholders' Equity Rule.
- Delisting Risk: If the Company fails to evidence compliance with the Minimum Stockholders' Equity Rule at the time of its next periodic financial statements, it may again be subject to delisting.
- Remediation Process: In the event of a deficiency, the Nasdaq Staff would provide written notice, and the Company retains the right to appeal to a Nasdaq Hearings Panel.
Investor Verification Checklist
- Verify the Company's current stockholders' equity balance in the most recent audited financial statements.
- Confirm the timeline for the next periodic financial statement filing to assess the window for maintaining compliance.
- Review the Company's capital structure to understand the buffer against future equity rule violations.